Evidence map›Paper›PMID 38964889›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Clinical management of thrombocytopenia in cirrhosis].

J P Li, Y Tan, H Sun, G Q Lin, B B Chen, Y Wu, Z W Xie, Y P Wang, A Q Lu, Y J Guan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J P LiDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Y TanDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
H SunDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
G Q LinDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
B B ChenDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Y WuDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Z W XieDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Y P WangDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
A Q LuDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
Y J GuanDepartment of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.

Funding

2023 Municipal-University (Institute)-Enterprise Joint Funding Special Project 2023A03J0786Guangzhou Medical University 2024 Research Capacity Enhancement Program Major Clinical Research Project GMUCR2024-02027, GMUCR2024-01017Guangzhou Science and Technology Bureau Municipal-University (Institute) Joint Funding Project 2024A03J0860
6 · The paper itself

Abstract

Thrombocytopenia is one of the common complications of cirrhotic patients, which can induce an increasing bleeding risk and closely correlate with bleeding following invasive procedures. Consequently, how to respond to thrombocytopenia is crucial for improving the prognosis of patients with cirrhosis. This article reviews the main mechanisms of cirrhosis concurrent with thrombocytopenia, as well as the corresponding clinical management strategies.

Indexed as

Liver CirrhosisThrombocytopeniaHumansIntervention strategiesLiver cirrhosisThrombocytopenia

Identifiers

PMID38964889
PMCPMC12898959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.